Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-19-026703
Filing Date
2019-12-20
Accepted
2019-12-20 16:33:04
Documents
3
Period of Report
2020-02-10
Effectiveness Date
2019-12-20

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT def14a1219_citiuspharma.htm DEF 14A 561660
2 GRAPHIC image_001.jpg GRAPHIC 773271
3 GRAPHIC image_002.jpg GRAPHIC 335188
  Complete submission text file 0001213900-19-026703.txt   2089485
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 001-38174 | Film No.: 191302028
SIC: 2834 Pharmaceutical Preparations